Alcor News

Alcor News

News Blog of the Alcor Life Extension Foundation

Member A-2408 becomes Alcor’s 175th patient on November 16, 2019

A-2408 was a confidential, 52-year-old, male with whole-body arrangements for cryopreservation. He had been a member since 2009 and had stage IV lung cancer. He was pronounced clinically dead in New Jersey on November 16, 2019, at 07:29 hrs. MST.

He was flown to Alcor for cryoprotection and entered cryogenic cool down on November 17, 2019. Three members of the Alcor New York group drove to New Jersey to assist with shipping the patient to Alcor; their participation was invaluable. He become Alcor’s 175th patient.

Member A-2366 becomes Alcor’s 174th patient on October 6, 2019

Member A-2366, a confidential, male neuro member was pronounced on October 6, 2019 in Washington state. After arriving early in the morning of October 7, A-2366 was perfused with cryoprotectant and entered cool down.

Two team members arrived at the member’s location on September 29 to check on him. That morning, we learned that the member’s doctor said A-2366 was better and seemed to be recovering. The doctor and family looked to moving him to a skilled nursing facility if he continued to improve. The Alcor team felt that he was still at significant risk and so remained. The next day, while we continued to be concerned about his condition, his doctor remained optimistic, saying that he continued to improve slowly. On October 1 we were told that the hospital planned to discharge the member to return to a rehab facility. Plans changed frequently.

On the morning of October 5, the hospice nurse said she believed the member would go down in the next 48 hours. Alcor CEO, Max More, immediately called for a deployment by Suspended Animation. They arrived that afternoon. Less than 24 hours later, on October 6, the member was pronounced, and SA conducted a washout and other standard procedures. On October 7, A-2366 arrived at Alcor and underwent cryoprotective perfusion followed by cool down for long-term storage.

Job opening: Medical Response Director

MEDICAL RESPONSE DIRECTOR

Job Description:
Alcor Life Extension Foundation is seeking a Medical Response Director (MRD) to join our high-functioning team. Reporting directly to the Chief Operating Officer, the MRD is responsible for the postmortem stabilization and transport of Alcor patients to Scottsdale, Arizona. The MRD will coordinate with Alcor staff and contractors to enhance existing Standby, Stabilization, and Transport (SST) processes. The MRD will ensure that equipment is properly maintained for emergency deployment and that the highest quality of care is delivered to our patients.

The MRD will collect appropriate data and ensure detailed, timely field reports are written. The MRD will be responsible for recruiting medically-skilled contractors, supervising the certification process for contractors, and implementing national and international training sessions. The MRD will work with Alcor personnel, external physicians, scientists, and consultants to ensure that procedures reflect the best available medical and scientific knowledge.

Job Responsibilities include, but are not limited to:
• Establish and maintain contact with Alcor member’s physician or medical facility upon terminal diagnosis and track member’s condition.
• Collaborate with Deployment Committee to determine when to activate the SST Team.
• Organize and oversee standby process, in which technicians wait to perform post-mortem stabilization procedures.
• Establish contact with local funeral homes to assist in stabilization and transport preparations.
• Interact with patients, families, and local medical personnel after pronouncement of legal death.
• Ensure timely application of Alcor’s SST protocol; which includes surface cooling, medication administration, cardiopulmonary support, airway management, and blood washout.
• Supervise patient transport to Scottsdale, Arizona and assist in Alcor’s operating room.
• Prepare detailed field reports on the care provided to the patient after transport is concluded.

Minimum Qualifications:
• College Degree, preferably healthcare related.
• 3+ years of experience in a healthcare field.
• Familiarity with HIPAA regulations and compliance with the Privacy Rule.
• Capable of lifting, minimally, 50 lbs.
• Intermediate proficiency with MS Office products.
• Ability to work in a collaborative team environment and must be comfortable with end of life process.

Preferred Qualifications:
• Registered Nurse, Paramedic, or Certified Perfusionist.
• 5+ years of experience in a healthcare field.
• 3+ years managerial experience.

Benefits:
• Competitive salary.
• 401k with 5% employer contributions.
• Health, Dental, and Vision insurance.
• 10 paid holidays per year, plus generous vacation and sick time policy.
• Tuition reimbursement for qualified staff.

Travel is approximately 30%.

Member A-3217 becomes Alcor’s 173rd patient on September 30, 2019

A-3217, a confidential, 55-year old, female, neurocryopreservation member, was pronounced legally dead on September 30, 2019 in Alberta, Canada.

A-3217 had been a member of Alcor since January 31, 2019. In August her family alerted Alcor that her cancer was progressing. Alcor suggested relocating the member to a Scottsdale, Arizona hospice. This would eliminate transport delays and avoid possible legal and regulatory problems due to Alberta’s jurisdiction. A late relocation is never easy and the family decided not to pursue that option.

While engaging in a standby for another member on the West Coast, Alcor heard from the family on September 30, 2019. Her physicians did not expect her to live more than 24 hours. Based on new information, a medical advisor agreed that an immediate deployment was called for. Alcor immediately relocated a team member from the West Coast to Alberta and engaged International Cryomedicine Experts (ICE) to take charge of stabilization and transport. Several Alcor staff provided additional coordination and logistics planning.

The member had declined unexpectedly rapidly. Just the day before pronouncement, the member’s spouse said that doctors thought A-3217 had another couple of weeks. The shortage of time combined with bad weather (delaying flights from the USA) and local regulations to create major barriers to a timely response. The challenges were met with strong teamwork, cooperation from the family, and efforts by the funeral home to expedite the required transit permit. Team members administered some medications early on followed by additional medications when more team members arrived.

The funeral home had originally told Alcor that it would take three days to get a transit permit. By going to the relevant office in person they hoped to get a same-day release. In the end, we had to wait overnight as the patient cooled to get clearance to move. Even though there was no funding for a private flight, Alcor decided to secure one in order to shave crucial time off the transport. This enabled us to conduct cryoprotection despite a longer transport time than desired.

Members who do not provide funding for a private flight should not expect Alcor to arrange one. In this case, the decision was justified by our ability to also use the flight to get a full field neurocryopreservation kit into Canada.

A-3217 arrived at Alcor on October 1, 2019. After cryoprotection she went into cryogenic cooldown at 19:36 hrs.

2019 Annual Meeting Election Results

DIRECTORS
All directors were unanimously re-elected:
Mike Anzis
Andy Aymeloglu
Ralph Merkle, Ph.D.
Mike O’Neal, Ph.D.
Michael Riskin, Ph.D., CPA
Michael Seidl, Ph.D., J.D.
Brian Wowk, Ph.D.

OFFICERS
President: Max More was re-relected unanimously.
COO: Patrick Harris was re-elected unanimously.
CFO/treasurer: Michael Perry was re-relected unanimously.
Secretary: Michael Perry was re-relected unanimously.
VP of finance: Bonnie Magee reelected unanimously.

Jianhau Ma, member A-3259, becomes Alcor’s 171st patient on August 8, 2019

Jianhau Ma, Alcor member A-3259, a non-confidential 50-year old female Alcor member with whole-body cryopreservation arrangements, was pronounced legally dead on August 8, 2019 in Boston, MA. She had stage IV ovarian cancer and had been an Alcor member for less than a month. Washout in the field was prevented by bad weather prohibiting the team from getting to the patient in time. In order to reduce ischemic time, the patient was flown by air ambulance to Alcor where whole-body perfusion was performed.

Cryogenic cooldown was initiated on August 9, 2019 and terminated on August 15, 2019. That day, Jianhau became Alcor’s 171st patient.

Annual Meeting of the Alcor Board, September 14, 2019

The 2019 Alcor Annual Meeting will be held on Saturday September 14, 2019, starting at 1:00 pm (MST) at the Thunderbird Suites Best Western conference room (7515 E Butherus Dr, Scottsdale, AZ 85260). The elections of directors and officers will be conducted at this meeting and a wide range of topics will be discussed publicly until 3:00 pm. Members and the public are encouraged to attend this meeting. The 2019 Strategic Meeting is also scheduled the same weekend, including Friday and Sunday sessions. Some sessions are closed but a summary of the topics discussed at the 2019 Strategic Meeting will be posted to our blog and newsletter.

Please note: The start time of the public meeting may change. If you cannot attend in person, you can use our teleconference system to call in using just audio or audio and video. Send a request to for call-in information.